ibrutinib & chemotherapy (teddi-r) in the treatment of secondary cns lymphoma
Published 7 months ago • 185 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
1:36
improved survival associated with ibrutinib compared to chemotherapy in mcl with cns relapse
-
3:09
takeaim lymphoma: emavusertib ibrutinib in r/r hematological malignancies
-
1:05
final analysis of the alpine trial: zanubrutinib vs ibrutinib in r/r cll
-
1:21
ibrutinib, rituximab and venetoclax in the treatment of patients with newly diagnosed mcl
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
1:56
ibrutinib treatment and its associated risk factors
-
3:56
phase i study of tinostamustine in pre-treated patients with r/r hodgkin lymphoma
-
1:29
insights into the uses of ibrutinib for patients with waldenström’s macroglobulinemia
-
5:59
6-year results of cll14: venetoclax-obinutuzumab for previously untreated cll
-
4:02
living with chronic lymphocytic leukaemia (cll)
-
11:51
uncw clr interim analyses and study closeout
-
2:18
zanubrutinib for r/r primary cns lymphoma: the initial results of the prizm platform study
-
1:24
the long-term safety and efficacy of ibrutinib monotherapy in patients with previously-treated wm
-
3:58
phase ib/iia study of azd4573 acalabrutinib in r/r dlbcl
-
4:31
sequence of administration of ibrutinib with obinutuzumab in r/r cll patients
-
3:27
the safety and efficacy of acalabrutinib for the treatment of r/r mzl
-
6:05
real-world data on the effect of ibrutinib flexible dosing treatment strategies on ttnt in cll/sll
-
4:42
ibrutinib, bruton’s tyrosine kinase inhibitor, for non-hodgkin lymphoma
-
2:39
the safety and efficacy of ibrutinib for the treatment of cll
-
5:41
primary results from the phase iii shine study: ibrutinib br for older patients with mcl
-
2:23
zilo-301: phase iii study of zilovertamab ibrutinib vs ibrutinib in r/r mcl
-
1:35
pirtobrutinib in r/r fl: results from the bruin study